what is that? Hamburg-based skin care giant Beiersdorf has announced its breakthrough in anti-aging research with the introduction of Glycostop™, a patented active ingredient designed to combat glycation, the process that accelerates skin aging due to sugar. announced significant progress. This innovation is the culmination of his 10 years of research, including testing approximately 1,700 substances.
detail Glycation is a natural but harmful chemical reaction in which sugar molecules combine with proteins, significantly reducing skin elasticity and elasticity, causing wrinkles and yellowish discoloration. Beiersdorf’s new ingredient NAHP (N-Acetyl-L-Hydroxyproline) effectively prevents the formation of harmful advanced glycation end products (AGEs) by up to 68% and protects collagen and elastin fibers in the skin. This breakthrough was led by Dr. Gitta Neufang and her team of over 1,000 researchers and built on Beiersdorf’s legacy of anti-aging innovations such as Coenzyme Q10.
The reason is? This groundbreaking development not only strengthens Beiersdorf’s portfolio in the anti-aging market, but also sets new standards in skin care technology. The April 2024 launch of Nivea Q10 Dual Action Serum combines ‘Glycostop™’ and his Q10 to provide consumers with a powerful dual action formula that tackles wrinkles and skin aging from the root. The product is in line with the company’s sustainability efforts, featuring eco-friendly packaging and formulations free of harmful additives.
